
<rdf:RDF xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:svcs="http://rdfs.org/sioc/services#" xmlns:doap="http://usefulinc.com/ns/doap#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
  
<ore:Aggregation rdf:about="https://door.donau-uni.ac.at/o:5152/#Aggregation">
  
<edm:aggregatedCHO rdf:resource="https://door.donau-uni.ac.at/o:5152"></edm:aggregatedCHO>

  
<edm:dataProvider>University for Continuing Education Krems</edm:dataProvider>

  
<edm:isShownAt rdf:resource="https://door.donau-uni.ac.at/o:5152"></edm:isShownAt>

  
<edm:isShownBy rdf:resource="https://door.donau-uni.ac.at/api/object/o:5152/get"></edm:isShownBy>

  
<edm:object rdf:resource="https://door.donau-uni.ac.at/api/object/o:5152/thumbnail"></edm:object>

  
<edm:rights rdf:resource="http://creativecommons.org/licenses/by-nc/4.0/"></edm:rights>

  
</ore:Aggregation>

  
<edm:ProvidedCHO rdf:about="https://door.donau-uni.ac.at/o:5152">
  
<dc:title xml:lang="en">A Narrative Review of SARS-CoV-2 Pathogenesis, Transmission, and Clinical Manifestations</dc:title>

  
<dc:description xml:lang="en">Background: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has
become a major global concern. As of writing this manuscript, there are over 224 million cases
diagnosed, and 4.5 million recorded deaths with the Coronavirus Disease 2019 (COVID-19).
Objectives: This article reviews the studies conducted on SARS-CoV-2 pathogenesis,
transmission, and different clinical manifestations.
Methods: An extensive online search was conducted on PubMed and Google Scholar search
engines. The following keywords and their combinations were used to complete this review:
“SARS-CoV-2”, “COVID-19”, “virology”, “mechanism of action”, “transmission”, “clinical
manifestations”, “laboratory findings”, and “comorbidities.”
Results: The SARS-CoV-2 spike glycoprotein recognizes the human angiotensin-converting
enzyme 2 receptors, and through that, the virus can enter its host cell. The virus is mainly
transmitted via respiratory and or airborne droplets. The severity of the COVID-19 clinical
manifestations relies on the associated comorbidities and or old age, which ranges from little-
to-no symptoms to severe and critical conditions. Fever, loss of appetite and or smell, fatigue,
and dry cough are among the most reported symptoms. Underlying conditions may lead to
severe or critical stages of COVID-19.
Conclusion: The SARS-CoV-2 nucleocapsid and receptor-binding domain could be two
potential targets for future vaccines and drugs. It appears that the virus is adapting to each
region’s specific environment; therefore, new endemic variants are forming.</dc:description>

  
<dc:identifier rdf:resource="https://door.donau-uni.ac.at/o:5152"></dc:identifier>

  
<dc:language>en</dc:language>

  
<edm:type>TEXT</edm:type>

  
<dc:type>journal article</dc:type>

  
<dc:type>Wissenschaftlicher Artikel</dc:type>

  
<dc:type xml:lang="en">Text</dc:type>

  
<dc:type xml:lang="en">journal article</dc:type>

  
<dc:type xml:lang="de">Text</dc:type>

  
<dc:type xml:lang="de">Wissenschaftlicher Artikel</dc:type>

  
<dc:subject xml:lang="en">COVID-19</dc:subject>

  
<dc:subject xml:lang="en">SARS-CoV-2</dc:subject>

  
<dc:subject xml:lang="en">Etiology</dc:subject>

  
<dc:subject xml:lang="en">Transmission</dc:subject>

  
<dc:subject xml:lang="en">Signs</dc:subject>

  
<dc:subject xml:lang="en">Symptoms</dc:subject>

  
<dcterms:issued>2022-08</dcterms:issued>

  
<dc:date>2022-08</dc:date>

  
<dc:creator>Amin Sharifan</dc:creator>

  
<dc:publisher>Mazandaran University of Medical Research</dc:publisher>

  
<dcterms:isPartOf></dcterms:isPartOf>

  
<dcterms:isPartOf></dcterms:isPartOf>

  
</edm:ProvidedCHO>

  
<edm:WebResource rdf:about="https://door.donau-uni.ac.at/api/object/o:5152/get">
  
</edm:WebResource>

  
</rdf:RDF>


